Adiponectin expression is highly associated with the risk of cancer in obesity-associated cancers such as hematologic malignancies, renal cancer, colon cancer, post-menopausal breast cancer, and endometrial cancer [194]. This evidence concerns the gene ADIPOQ and cancer.